Oragenics Inc
OGENNYSECIK 1174940HealthcareFiscal year ends Dec 31
Reports and events: 419 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1604:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-042843 |
| 2026-08-2813:06 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-040645 |
| 2026-08-1316:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037749 |
| 2026-07-0616:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-032155 |
| 2026-05-2016:05 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001493152-26-024602 |
| 2026-05-1908:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024363 |
| 2026-05-0816:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-021967 |
| 2026-05-0708:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-021627 |
| 2026-04-1308:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-016294 |
| 2026-03-3116:05 ET | 8-K | 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-26-014128 |
| 2026-03-1616:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-010282 |
| 2026-03-1116:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009682 |
| 2026-01-2216:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-003237 |
| 2026-01-2008:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-002759 |
| 2025-12-1516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-027745 |
| 2025-11-1208:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-021749 |
| 2025-11-0716:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021257 |
| 2025-10-2107:45 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-018725 |
| 2025-09-0216:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-012562 |
| 2025-08-1108:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-022908 |
| 2025-08-0816:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-022766 |
| 2025-07-0216:30 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-017575 |
| 2025-06-3013:28 ET | S-1/A | Registration statement, amended | 0001641172-25-017088 |
| 2025-06-2306:18 ET | S-1 | Registration statement | 0001641172-25-015984 |
| 2025-05-2807:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-012596 |
| 2025-05-2017:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-011774 |
| 2025-05-0916:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009464 |
| 2025-05-0216:45 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-008389 |
| 2025-04-0908:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-003334 |
| 2025-04-0116:30 ET | DEF 14A | Proxy statementPeriod 2025-04-01 | 0001641172-25-002090 |
| 2025-03-2708:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-000855 |
| 2025-03-1416:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-010389 |
| 2025-03-0609:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-009335 |
| 2025-02-1816:30 ET | 8-K | 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-25-007182 |
| 2025-02-0508:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-004946 |
| 2025-01-2108:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-002928 |
| 2025-01-1716:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-002751 |
| 2025-01-0806:06 ET | S-1/A | Registration statement, amended | 0001493152-25-001268 |
| 2024-12-3111:47 ET | S-1/A | Registration statement, amended | 0001493152-24-052623 |
| 2024-12-1810:00 ET | S-1 | Registration statement | 0001493152-24-050649 |
| 2024-12-1616:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-050216 |
| 2024-11-2917:00 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-048190 |
| 2024-11-1314:40 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045067 |
| 2024-10-3109:15 ET | DEF 14A | Proxy statementPeriod 2024-10-31 | 0001493152-24-043144 |
| 2024-10-1808:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-041500 |
| 2024-10-1610:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-041255 |
| 2024-10-1518:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-040974 |
| 2024-10-0907:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-040523 |
| 2024-09-2016:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-24-037602 |
| 2024-09-0516:45 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-035166 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.